Adrian Rawcliffe - Net Worth and Insider Trading

Adrian Rawcliffe Net Worth

The estimated net worth of Adrian Rawcliffe is at least $37,094 dollars as of 2024-11-05. Adrian Rawcliffe is the CEO of Adaptimmune Therapeutics PLC and owns about 44,848 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $37,094. Details can be seen in Adrian Rawcliffe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adrian Rawcliffe has not made any transactions after 2024-01-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Adrian Rawcliffe

To

Adrian Rawcliffe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adrian Rawcliffe owns 2 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , and WAVE Life Sciences Ltd (WVE) .

Click here to see the complete history of Adrian Rawcliffe’s form 4 insider trades.

Insider Ownership Summary of Adrian Rawcliffe

Ticker Comapny Transaction Date Type of Owner
ADAP Adaptimmune Therapeutics PLC 2024-01-17 Chief Financial Officer
WVE WAVE Life Sciences Ltd 2017-02-01 director

Adrian Rawcliffe Latest Holdings Summary

Adrian Rawcliffe currently owns a total of 1 stock. Adrian Rawcliffe owns 44,848 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 17, 2024, with a value of $37,094.

Latest Holdings of Adrian Rawcliffe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADAP Adaptimmune Therapeutics PLC 2024-01-17 44,848 0.83 37,094

Holding Weightings of Adrian Rawcliffe


Adrian Rawcliffe Form 4 Trading Tracker

According to the SEC Form 4 filings, Adrian Rawcliffe has made a total of 20 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 39,384 shares on January 17, 2024, which brought Adrian Rawcliffe around $27,569.

Insider Trading History of Adrian Rawcliffe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Adrian Rawcliffe Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Adrian Rawcliffe Ownership Network

Ownership Network List of Adrian Rawcliffe

No Data

Ownership Network Relation of Adrian Rawcliffe

Insider Network Chart

Adrian Rawcliffe Owned Company Details

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Adrian Rawcliffe is the Chief Financial Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Adrian Rawcliffe made 4 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 73,322. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 35,120 shares made by John Lunger , a net sale of 32,818 shares made by Bertrand William C Jr , and a net sale of 32,371 shares made by Elliot Norry .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

Adrian Rawcliffe Mailing Address

Above is the net worth, insider trading, and ownership report for Adrian Rawcliffe. You might contact Adrian Rawcliffe via mailing address: 440 South Broad Street, Unit 1906, Philadelphia Pa 19146.